CRB Monitor Chart of the Month | February 2024
It has been about a year since we have written about the sometimes dysfunctional relationship amongst Tier 1 Pure Play, Tier 2, and Tier 3 cannabis-related businesses... Read more.
Cannabis-linked Securities Update | February 2024 | Cannabis Index Returns
February reminded us once again that “we can’t have nice things” in the cannabis market, at least not for very long. And as the equity markets rallied over... Read more.
Cannabis-Related Securities | Monthly Update | January 2024
January 2024 provided further evidence that the cannabis industry not only has a pulse but might actually pull itself together and survive the years-long regulatory... Read more.
Cannabis-Related Securities | Quarterly Update | Fourth Quarter 2023
The CRB Monitor Securities Research team covers all aspects of the publicly-traded cannabis ecosystem, including the regulatory environment, operational expansion/M&A... Read more.
Cannabis-Related Securities | Monthly Update | December 2023
December 2023 provided, if nothing else, a ray of hope for those investors that have stuck around for the duration of this performance history that boasts all the... Read more.
Cannabis-Related Securities | Monthly Update | November 2023
November 2023 had cannabis investors saying, “Well, at least it didn’t tank again”. In fact, they were treated to returns that reflected either 1) optimism... Read more.
Cannabis-Related Securities | Monthly Update | October 2023
October 2023 saw precious little support for cannabis equities (see above), and many CRBs returned to their pre-HHS rescheduling announcement lows. We are all old... Read more.
Cannabis-Related Securities Quarterly Update | Third Quarter 2023
The CRB Monitor Securities Research team covers all aspects of the publicly-traded cannabis ecosystem, including the regulatory environment, operational expansion/M&A... Read more.
Cannabis-Related Securities Monthly Update | September 2023
With the hysteria over The announcement that the US Department of Health and Human Services recommended rescheduling cannabis to Schedule III from Schedule I now... Read more.
CRB Monitor Chart of the Month | September 2023
This month we take a closer look at the near-term health of the largest 20 pure play Tier 1 CRBs, as we consider what investors have to look forward to given the... Read more.
